Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
174.1 USD | -0.41% | +3.21% | +12.33% |
Feb. 09 | ETF of the week: Dividend lovers are in luck | |
Feb. 08 | AbbVie's VYALEV?? (foslevodopa/Foscarbidopa Solution) Available for the Treatment of Advanced Parkinson's Disease in Canada | CI |
Financials (USD)
Sales 2023 | 54.32B | Sales 2024 * | 54.42B | Capitalization | 307B |
---|---|---|---|---|---|
Net income 2023 | 4.86B | Net income 2024 * | 9.57B | EV / Sales 2023 | 5.04 x |
Net Debt 2023 * | 45.68B | Net Debt 2024 * | 46.42B | EV / Sales 2024 * | 6.5 x |
P/E ratio 2023 |
57
x | P/E ratio 2024 * |
31.3
x | Employees | 50,000 |
Yield 2023 * |
3.42% | Yield 2024 * |
3.56% | Free-Float | 96.74% |
Latest transcript on AbbVie Inc.
1 day | -0.41% | ||
1 week | +3.21% | ||
Current month | +5.89% | ||
1 month | +5.57% | ||
3 months | +25.61% | ||
6 months | +14.95% | ||
Current year | +12.33% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 12-12-31 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 12-12-31 |
Robert Michael
PSD | President | 53 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 12-12-31 |
Edward Rapp
BRD | Director/Board Member | 66 | 12-12-31 |
Director/Board Member | 70 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 6 M€ | +0.93% | - | |
6.85% | 19 M€ | +2.97% | - | |
6.26% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-02-09 | 174.1 | -0.41% | 3,502,661 |
24-02-08 | 174.8 | -0.13% | 5,709,326 |
24-02-07 | 175 | +0.99% | 6,409,084 |
24-02-06 | 173.3 | +1.19% | 7,038,000 |
24-02-05 | 171.3 | +1.54% | 6,486,886 |
Delayed Quote Nyse, February 09, 2024 at 04:00 pm EST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.33% | 307 B $ | |
+26.97% | 666 B $ | |
+19.17% | 536 B $ | |
+0.01% | 377 B $ | |
+15.07% | 318 B $ | |
-8.02% | 207 B $ | |
+4.05% | 206 B $ | |
-7.92% | 191 B $ | |
-4.27% | 156 B $ | |
-3.63% | 117 B $ |